Invention is our culture, and we are in a unique position of pioneering an entirely new field. From the outset of the company’s founding, we have focused on building a dominant intellectual property estate, and have met the quantum potential of messenger RNA Therapeutics™ by developing an IP portfolio that will allow us to freely conduct our activities, protect our valuable assets, and maintain our exclusive rights.

One of our earliest priorities was the establishment of a multi-disciplinary, experienced, and creative intellectual property team who are passionate, and who think big. Our patent portfolio reflects this mindset: we have implemented a thorough and comprehensive intellectual property strategy, having filed 120 patent applications reciting 6,500 claims directed to the company’s technology platform and drug discovery and development programs, including novel chemical modifications, RNA engineering, formulation, composition of matter, route of administration, and dosing paradigms.

That’s just the beginning.